People with COVID 19 whose disease has been confirmed by Real Time PCR. U07.1
Conditions
Interventions
Intervention 1: Consumption of capsules containing licorice extract in the intervention group.Alcoholic extract of licorice root will be purchased from Shirin Daroo Company and will be received in ste
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Includes people with laboratory confirmation of Quid 19 virus regardless of clinical signs and close association Age over 15 years
Exclusion criteria
Exclusion criteria: Patient request to leave the study for any reason Request the treating physician to exclude the patient from the study for any reason History of drug allergies History of allergies Patients with immunodeficiency Patients with hypertension Group of patients with underlying disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 6( IL-6). Timepoint: Major measurements of variables are performed on the first day before the intervention and on the 10th day after the intervention. Method of measurement: Using the kit.;Interleukin One Beta( IL-1ß). Timepoint: Major measurements of variables are performed on the first day before the intervention and on the 10th day after the intervention. Method of measurement: Using the kit.;Alpha tumor necrosis factor(TNF-a). Timepoint: Major measurements of variables are performed on the first day before the intervention and on the 10th day after the intervention. Method of measurement: Using the kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| The international normalized ratio (INR). Timepoint: Sampling is done on the first day before the intervention and on the 10th day after the intervention for the main and routine variables of the study. Method of measurement: Through a clinical laboratory.;D -Dimmer. Timepoint: Sampling is done on the first day before the intervention and on the 10th day after the intervention for the main and routine variables of the study. Method of measurement: Through a clinical laboratory.;Fibrinogen. Timepoint: Sampling is done on the first day before the intervention and on the 10th day after the intervention for the main and routine variables of the study. Method of measurement: Through a clinical laboratory.;Ferritin. Timepoint: Sampling is done on the first day before the intervention and on the 10th day after the intervention for the main and routine variables of the study. Method of measurement: Through a clinical laboratory.;C Reactive Protein (CRP). Timepoint: Sampling is done on the first day before the intervention and on the 10th day after the intervention for the main and routine variables of the study. Method of measurement: Through a clinical laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMrs Shokofe Noori
Shahid Beheshti University of Medical Sciences
Outcome results
None listed